However, in breast and other cancer cell types, meaningful response is inconsistent as a result of reduced or heterogeneous PD-L1 expression, immunosuppressive mechanisms, impaired immune cell function and trafficking of TILs (87, 89), resulting in paradoxical PD-L1+ “non-responders” and PD-L1low/null “responders”. Here, CD274 is linked to cancer.